Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL
在B细胞非霍奇金淋巴瘤患者中，自体造血干细胞移植后采用中央记忆来源的CD19 CAR T细胞疗法的I期研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood-2015-12-686725
Wang, Xiuli; Popplewell, Leslie L; Wagner, Jamie R; Naranjo, Araceli; Blanchard, M Suzette; Mott, Michelle R; Norris, Adam P; Wong, ChingLam W; Urak, Ryan Z; Chang, Wen-Chung; Khaled, Samer K; Siddiqi, Tanya; Budde, Lihua E; Xu, Jingying; Chang, Brenda; Gidwaney, Nikita; Thomas, Sandra H; Cooper, Laurence J N; Riddell, Stanley R; Brown, Christine E; Jensen, Michael C; Forman, Stephen J
B细胞
发育与干细胞
T细胞
淋巴瘤
T细胞
干细胞
细胞生物学
CD19
免疫/内分泌
